Market Cap 549.54M
Revenue (ttm) 573.28M
Net Income (ttm) -33.54M
EPS (ttm) N/A
PE Ratio 14.08
Forward PE 10.24
Profit Margin -5.85%
Debt to Equity Ratio 1.87
Volume 358,300
Avg Vol 410,868
Day's Range N/A - N/A
Shares Out 82.14M
Stochastic %K 59%
Beta 0.86
Analysts Strong Sell
Price Target $12.33

Company Profile

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise of various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain. It also offers precision bone resection for pat...

Industry: Medical Devices
Sector: Healthcare
Phone: 919 474 6700
Address:
4721 Emperor Boulevard, Suite 100, Durham, United States
swingingtech
swingingtech Jun. 20 at 12:08 PM
$FHLC $BVS $BCRX $AVBP https://wallstreetwaves.com/peek-under-the-hood-fhlc-has-21-upside/
0 · Reply
TheLearnerEarner
TheLearnerEarner May. 30 at 2:11 PM
$BVS ✅ Healthcare - Mid Cap - F-Score: 6/9 Analysts: 2x buy rating 👨‍🔬 Intrinsic Value Potential: Excellent 💎 RSI: 39.23 (oversold bullish) 📊🐂 Highest Analysts Price Target: $15.00 (130% above Price) 🌟 Range (12m) $5.28 - $14.38 💰 Positive Free Cash Flow: Yes 🏧 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/BVS/bioventus-reports-first-quarter-financial-uudx27wc3fec.html
0 · Reply
11thestate
11thestate May. 16 at 12:17 PM
$BVS agreed to a $15.25M settlement with investors over claims it misled them about unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who bought and held $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.49 per share — but if only 25% of eligible investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate May. 16 at 11:52 AM
$BVS agreed to a $15.25M settlement with investors over claims it misled them about unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who bought and held $BVS stock between November 21, 2022 and December 2, 2024. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.49 per share — but if only 25% of eligible investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate May. 9 at 12:14 PM
$BVS agreed to a $15.25M settlement with investors over claims it hid unexpected refund demands and financial issues tied to lower average selling prices. Who’s eligible? Anyone who bought and held $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.49 per share, depending on how many investors file. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
PenkeTrading
PenkeTrading May. 7 at 11:54 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Bioventus Inc. Is that bullish or bearish? $BVS #Bioventus #RsiOversold #NASDAQ
0 · Reply
11thestate
11thestate May. 2 at 12:14 PM
$BVS agreed to a $15.25M settlement with investors over claims it hid financial issues like unexpected refund demands and pricing problems. Who’s eligible? Anyone who bought $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, even if you still hold or already sold. How much is the payout? Estimated at $0.49 per share, but if only 25% of investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Typically 8–12 months after final court approval (scheduled for December 13, 2024). To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate Apr. 25 at 12:01 PM
$BVS agreed to a $15.25M settlement with investors over claims related to unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who purchased or otherwise acquired Bioventus ($BVS) common stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you’re eligible even if you still hold the shares, as long as you bought during the class period. How much is the payout? Estimated at $0.49 per share, depending on the number of valid claims submitted. Can I still file? Yes — late claims are being accepted, subject to court approval. When will payments go out? Payouts usually happen 8–12 months after the final approval hearing. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
Schillinator
Schillinator Apr. 13 at 12:21 AM
$ZETA it’s a frivolous lawsuit and how do we know because one of the plaintiffs (Jae Hyung Jung) recently filed a similar lawsuit against $BVS
0 · Reply
11thestate
11thestate Apr. 11 at 12:07 PM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought $BVS between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
Latest News on BVS
Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:55 PM EDT - 7 weeks ago

Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript


Bioventus Reports First Quarter Financial Results

May 6, 2025, 7:30 AM EDT - 7 weeks ago

Bioventus Reports First Quarter Financial Results


Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 2:31 PM EDT - 3 months ago

Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript


Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 12:26 PM EST - 8 months ago

Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript


Bioventus Reports Third Quarter Financial Results

Nov 5, 2024, 7:30 AM EST - 8 months ago

Bioventus Reports Third Quarter Financial Results


Executives Buying W. P. Carey And 2 Other Stocks

Aug 21, 2024, 7:37 AM EDT - 11 months ago

Executives Buying W. P. Carey And 2 Other Stocks

WPC GWRS


Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024

Aug 12, 2024, 11:01 AM EDT - 11 months ago

Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024


Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 1:45 PM EDT - 11 months ago

Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript


Bioventus Reports Second Quarter Financial Results

Aug 6, 2024, 7:30 AM EDT - 11 months ago

Bioventus Reports Second Quarter Financial Results


Bioventus, Inc. (BVS) Q1 2024 Earnings Call Transcript

May 7, 2024, 12:02 PM EDT - 1 year ago

Bioventus, Inc. (BVS) Q1 2024 Earnings Call Transcript


Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 11:00 AM EDT - 1 year ago

Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript


Bioventus: Bullish On Path To Profitability

Jan 24, 2024, 2:00 PM EST - 1 year ago

Bioventus: Bullish On Path To Profitability


Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript

Nov 12, 2023, 12:55 AM EST - 1 year ago

Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript


Bioventus Stock: Improving Outlook Keeps It Interesting

Oct 11, 2023, 5:44 PM EDT - 1 year ago

Bioventus Stock: Improving Outlook Keeps It Interesting


Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 1:56 PM EDT - 2 years ago

Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript


Bioventus: Return Of The King

Jun 28, 2023, 2:18 PM EDT - 2 years ago

Bioventus: Return Of The King


Bioventus Completes Divestiture of its Wound Business

May 23, 2023, 7:30 AM EDT - 2 years ago

Bioventus Completes Divestiture of its Wound Business


Bioventus Inc. (BVS) Q1 2023 Earnings Call Transcript

May 16, 2023, 10:53 PM EDT - 2 years ago

Bioventus Inc. (BVS) Q1 2023 Earnings Call Transcript


Bioventus Announces Divestiture of its Wound Business

May 10, 2023, 9:00 AM EDT - 2 years ago

Bioventus Announces Divestiture of its Wound Business


Bioventus Announces CEO Leadership Change

Apr 5, 2023, 8:00 AM EDT - 2 years ago

Bioventus Announces CEO Leadership Change


Bioventus Inc. (BVS) Q4 2022 Earnings Call Transcript

Mar 31, 2023, 2:56 PM EDT - 2 years ago

Bioventus Inc. (BVS) Q4 2022 Earnings Call Transcript


swingingtech
swingingtech Jun. 20 at 12:08 PM
$FHLC $BVS $BCRX $AVBP https://wallstreetwaves.com/peek-under-the-hood-fhlc-has-21-upside/
0 · Reply
TheLearnerEarner
TheLearnerEarner May. 30 at 2:11 PM
$BVS ✅ Healthcare - Mid Cap - F-Score: 6/9 Analysts: 2x buy rating 👨‍🔬 Intrinsic Value Potential: Excellent 💎 RSI: 39.23 (oversold bullish) 📊🐂 Highest Analysts Price Target: $15.00 (130% above Price) 🌟 Range (12m) $5.28 - $14.38 💰 Positive Free Cash Flow: Yes 🏧 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/BVS/bioventus-reports-first-quarter-financial-uudx27wc3fec.html
0 · Reply
11thestate
11thestate May. 16 at 12:17 PM
$BVS agreed to a $15.25M settlement with investors over claims it misled them about unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who bought and held $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.49 per share — but if only 25% of eligible investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate May. 16 at 11:52 AM
$BVS agreed to a $15.25M settlement with investors over claims it misled them about unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who bought and held $BVS stock between November 21, 2022 and December 2, 2024. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.49 per share — but if only 25% of eligible investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate May. 9 at 12:14 PM
$BVS agreed to a $15.25M settlement with investors over claims it hid unexpected refund demands and financial issues tied to lower average selling prices. Who’s eligible? Anyone who bought and held $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.49 per share, depending on how many investors file. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after final approval. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
PenkeTrading
PenkeTrading May. 7 at 11:54 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Bioventus Inc. Is that bullish or bearish? $BVS #Bioventus #RsiOversold #NASDAQ
0 · Reply
11thestate
11thestate May. 2 at 12:14 PM
$BVS agreed to a $15.25M settlement with investors over claims it hid financial issues like unexpected refund demands and pricing problems. Who’s eligible? Anyone who bought $BVS stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, even if you still hold or already sold. How much is the payout? Estimated at $0.49 per share, but if only 25% of investors file, it could go up to $1.96 per share. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Typically 8–12 months after final court approval (scheduled for December 13, 2024). To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate Apr. 25 at 12:01 PM
$BVS agreed to a $15.25M settlement with investors over claims related to unexpected refund claims and financial reporting issues. Who’s eligible? Anyone who purchased or otherwise acquired Bioventus ($BVS) common stock between February 11, 2021 and November 21, 2022. Do I need to sell my shares to qualify? No — you’re eligible even if you still hold the shares, as long as you bought during the class period. How much is the payout? Estimated at $0.49 per share, depending on the number of valid claims submitted. Can I still file? Yes — late claims are being accepted, subject to court approval. When will payments go out? Payouts usually happen 8–12 months after the final approval hearing. To file your claim: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
Schillinator
Schillinator Apr. 13 at 12:21 AM
$ZETA it’s a frivolous lawsuit and how do we know because one of the plaintiffs (Jae Hyung Jung) recently filed a similar lawsuit against $BVS
0 · Reply
11thestate
11thestate Apr. 11 at 12:07 PM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought $BVS between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate Apr. 4 at 10:25 AM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought $BVS between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
11thestate
11thestate Mar. 28 at 11:20 AM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought $BVS between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 23 at 4:23 AM
$BVS Digging BVS medical tech strategy. Pain treatments and surgical solutions look promising. Might add to portfolio on next dip. Watching closely. noteworthy article: https://beyondspx.com/article/bioventus-inc-bvs-a-global-leader-driving-innovation-for-active-healing
0 · Reply
11thestate
11thestate Mar. 21 at 12:07 PM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11th.com/cases/bioventus-investor-lawsuit
0 · Reply
JarvisFlow
JarvisFlow Mar. 17 at 3:31 PM
Canaccord Genuity updates rating for Bioventus ( $BVS ) to Buy, target set at 15.
0 · Reply
11thestate
11thestate Mar. 14 at 10:27 AM
$BVS has agreed to a $15.25M settlement with investors to resolve claims related to financial issues, including unexpected refund claims from customers. Even if you missed the deadline, if you bought between February 11, 2021, and November 21, 2022, you still can file for payment here: https://11thestate.com/cases/bioventus-investor-lawsuit
0 · Reply
doumch
doumch Mar. 11 at 7:39 PM
$TRVI $DWTX $BVS Buyers building $TRVI back up at the close to 7 and break from there with all the analyst price target raises
0 · Reply
ajmrtxl
ajmrtxl Mar. 11 at 3:47 PM
$BVS' latest data on Squeezefinder
0 · Reply
jParkz
jParkz Mar. 11 at 2:00 PM
News $BVS Bioventus Reports Surge in Sales, Profitability, and Promise for 2025 https://marketwirenews.com/news-releases/bioventus-reports-surge-in-sales-profitability-and-p-8442379955221327.html $BVS
0 · Reply
_www_larval_com_
_www_larval_com_ Mar. 11 at 1:42 PM
$HMR -9%[-19%] $BVS 7%[27%] $CYN -5%[0%] $MLGO -5%[11%] $OSCR -4%[-14%] most notable movement within the first minutes of trading.
0 · Reply
StockElementCorporation
StockElementCorporation Mar. 11 at 1:04 PM
Premarket movers 📈 $SNOA +52% $TNON +41% $BVS +27% $MYO +26% $ONDS +24% LFMD +21% MNTS +17% LUV +10% XPEV +9.4% TXNM +8.4% PAY +7.4% HSAI +7.1% WATT +6.2% HLLY +5.0% ELV +4.8% MTN +4.8% UNFI +4.7% JBLU +4.3% SARO +4.2% KFY +3.9% VXRT +3.8% COIN +3.2% NNE +2.9% FOLLOW US FOR MORE LEVELS & ALERTS 📈
0 · Reply
OpenOutcrier
OpenOutcrier Mar. 11 at 12:31 PM
$BVS (+26.7% pre) Bioventus stock soars 28% on upbeat FY25 guidance following Q4 revenue beat https://ooc.bz/l/59113
0 · Reply